KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ClearPoint Neuro (CLPT) EBT Margin (2018 - 2026)

ClearPoint Neuro's EBT Margin history spans 13 years, with the latest figure at 74.76% for Q4 2025.

  • On a quarterly basis, EBT Margin fell 503.0% to 74.76% in Q4 2025 year-over-year; TTM through Dec 2025 was 68.93%, a 872.0% decrease, with the full-year FY2025 number at 68.93%, down 872.0% from a year prior.
  • EBT Margin hit 74.76% in Q4 2025 for ClearPoint Neuro, down from 66.39% in the prior quarter.
  • Over the last five years, EBT Margin for CLPT hit a ceiling of 54.08% in Q1 2024 and a floor of 119.85% in Q2 2023.
  • Historically, EBT Margin has averaged 78.55% across 5 years, with a median of 74.25% in 2022.
  • Biggest five-year swings in EBT Margin: tumbled -4651bps in 2021 and later skyrocketed 6394bps in 2024.
  • Tracing CLPT's EBT Margin over 5 years: stood at 96.82% in 2021, then rose by 11bps to 86.37% in 2022, then increased by 20bps to 69.1% in 2023, then fell by -1bps to 69.72% in 2024, then dropped by -7bps to 74.76% in 2025.
  • Business Quant data shows EBT Margin for CLPT at 74.76% in Q4 2025, 66.39% in Q3 2025, and 63.07% in Q2 2025.